Medizinische Universität Graz - Research portal
Wenzl Kerstin |
** = Publications listed in SCI/SSCI/Pubmed
2022
Full paper/article (Journal)
** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14):
Doi: 10.3390/ijms23147874
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.-64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 10-13, 2022; New Orleans, LA.
Doi: 10.1182/blood-2022-163034
[Poster]
Web of Science
FullText
FullText_MUG
2019
Abstract (Journal)
** Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135.
[Oral Communication]
Web of Science
** Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A
Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83.
[Poster]
Web of Science
2017
Full paper/article (Journal)
** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386
Doi: 10.1158/0008-5472.CAN-16-2320
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
2016
Full paper/article (Journal)
** Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330
Doi: 10.1136/jclinpath-2015-203356
Web of Science
PubMed
FullText
FullText_MUG
** Wenzl, K; Hofer, S; Troppan, K; Lassnig, M; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Neumeister, P; Deutsch, A
Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.
Tumour Biol. 2016; 37(4):4785-4789
Doi: 10.1007/s13277-015-4322-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Full paper/article (Journal)
** Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P
Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
PLoS One. 2015; 10(4):e0123922-e0123922
Doi: 10.1371/journal.pone.0123922
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, GG; Beham-Schmid, C; Neumeister, P; Deutsch, A
miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Int J Mol Sci. 2015; 16(8):18077-18095
Doi: 10.3390/ijms160818077
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544
Doi: 10.1111/ejh.12529
Web of Science
PubMed
FullText
FullText_MUG
Review
** Troppan, K; Wenzl, K; Neumeister, P; Deutsch, A
Molecular Pathogenesis of MALT Lymphoma.
Gastroenterol Res Pract. 2015; 2015(9):102656-102656
Doi: 10.1155/2015/102656
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzl, K; Troppan, K; Neumeister, P; Deutsch, AJ
The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Curr Drug Targets. 2015; 16(1):38-46
Doi: 10.2174/1389450115666141120112818
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Beham-Schmid, C; Neumeister, P
NR4A1 AND NR4A3 POSSESS FUNCTIONAL REDUNDANCY BY REGULATING PRO-APOPTOTIC GENES IN AGGRESSIVE LYMPHOMAS.
HAEMATOLOGICA. 2015; 100: 544-544.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
** Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P
NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA
The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA
Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
2014
Full paper/article (Journal)
** Deutsch, AJ; Rinner, B; Wenzl, K; Pichler, M; Troppan, K; Steinbauer, E; Schwarzenbacher, D; Reitter, S; Feichtinger, J; Tierling, S; Prokesch, A; Scheideler, M; Krogsdam, A; Thallinger, GG; Schaider, H; Beham-Schmid, C; Neumeister, P
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Blood. 2014; 123(15):2367-2377
Doi: 10.1182/blood-2013-08-518878
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neumeister, P; Pichler, M
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Br J Cancer. 2014; 110(2):369-374
Doi: 10.1038/bjc.2013.763
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Br J Cancer. 2014; 111(1):55-60
Doi: 10.1038/bjc.2014.277
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Troppan, K; Wenzl, K; Deutsch, A; Ling, H; Neumeister, P; Pichler, M
MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(2):557-564
Web of Science
PubMed
Abstract (Journal)
** Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Beham-Schmid, C; Neumeister, P
NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL
HAEMATOLOGICA. .. 2014; 99: 136-136.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135.
[Poster]
Web of Science
** Troppan, KT; Wenzl, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells
ONCOL RES TREAT. 2014; 37: 72-73.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Deutsch, A; Neumeister, P
ANALYSES OF NUCLEAR ORPHAN RECEPTOR EXPRESSION AND CYTOTOXICITY FOLLOWING ANTI-CD 20 MONOCLONAL ANTIBODY TREATMENT IN AGGRESSIVE NON-HODGKIN'S LYMPHOMAS
HAEMATOLOGICA. 2014; 99: 685-686.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival
ONCOL RES TREAT. 2014; 37: 73-73.
[Poster]
Web of Science
2013
Abstract (Journal)
** Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C;
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013)
Doi: 10.1182/blood.V122.21.4852.4852
Web of Science
FullText
FullText_MUG